Sumitomo Mitsui Financial Group (SMFG) is rated a 'Buy' with a potential 27% capital gain based on a target price-to-book ratio of 2.00x. The company has raised its fiscal year 2029 international income forecast to ¥0.14 trillion, driven by growth in its Indian and Indonesian operations, with foreign return on tangible equity expected to increase from 8.9% to 20%. SMFG's fintech superapp Olive aims for ¥0.11 trillion in earnings by FY29, supported by partnerships with 7-Eleven and new advisory services. Management prioritizes dividend growth over share buybacks, committing to annual dividend increases to attract income-focused investors.
Sumitomo Mitsui Financial Group's ambitious targets and dividend plans provide context for the financial sector's performance. For readers following financial stocks, here is Pluang's market snapshot as of Sep 17, 2026 23:31 WIB: Among 74 priced Financials-sector US stocks, 57 rose and 16 fell today. Banco Santander SA (SAN) gained 2.85% to USD 14.81 with 100% buy orders and a typical hold time of 54 days. Nasdaq Inc (NDAQ) rose 2.83% to USD 91.27, also with 100% buy orders and a typical hold time of 124 days. Prospect Capital Corporation (PSEC) increased 2.73% to USD 2.26 but saw 91% sell orders and a typical hold time of 76 days.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
